Rapid Micro Biosystems RPID Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -144.2%-3.1pp | -141.1%+7.7pp | -148.8%+3.4pp | -152.1%+7.5pp | -159.6%+18.4pp | |
| Net margin | -145.8%-5.5pp | -140.3%+4.8pp | -145.1%+0.5pp | -145.6%+5.6pp | -151.2%+15.9pp | |
| EBITDA margin | -135.2%-3.7pp | -131.4%+6.4pp | -137.9%+3.1pp | -140.9%+7.2pp | -148.1%+17.9pp | |
| Free cash flow margin | -110.5%-15.4pp | -95%+31.4pp | -126.4%0.0pp | -126.4%+4.5pp | -130.9%+31.4pp | |
| Returns | ||||||
| Return on equity | -116.7%-29.9pp | -86.8%-18.0pp | -68.8%-9.7pp | -59.2%-6.9pp | -52.3%-3.8pp | |
| Return on assets | -67.8%-13.4pp | -54.5%-7.9pp | -46.6%-0.8pp | -45.8%-3.7pp | -42.1%-3.2pp | |
| Return on invested capital | -120.6%-26.9pp | -93.7%-16.7pp | -77.1%+10.2pp | -87.3%-20.9pp | -66.4%-5.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.1× | 0.4×+0.1× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.6×-0.7× | 3.3×-0.9× | 4.2×+0.6× | 3.7×-0.9× | 4.6×0.0× | |
| Quick ratio | 1.7×-0.7× | 2.4×-0.6× | 3×+0.5× | 2.4×-0.8× | 3.2×-0.2× | |
| Cash ratio | 0.7×-0.4× | 1.1×-0.1× | 1.2×0.0× | 1.1×-0.2× | 1.3×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×+0.4× | 0.7×+0.2× | 0.5×+0.4× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.4×+0.1× | 0.3×0.0× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -24.1×+9.0× | -33.2×+26.0× | -59.1×+60.2× | -119.4×-65.2× | -54.2×-27.1× | |
| Per Share | ||||||
| Book value per share | $0.45-39.6% | $0.74-24.6% | $0.99-19.3% | $1.22-17.9% | $1.49-13.9% | |
| Valuation | ||||||
| Market capitalization | $86.19M-43.8% | $128.54M-13.0% | $147.66M-0.3% | $148.15M+29.8% | $114.14M+195% | |
| Enterprise value | $95.86M-31.7% | $132.15M-13.4% | $152.59M+12.9% | $135.16M+34.1% | $100.8M+264% | |
| Price / sales | 2.5×-2.6× | 3.8×-1.0× | 4.8×-0.1× | 4.9×+1.0× | 3.9×+2.5× | |
| Price / book | 4.2×+1.4× | 3.9×+0.5× | 3.3×+0.6× | 2.7×+1.0× | 1.7×+1.2× | |
| EV / sales | 2.8×-1.8× | 3.9×-1.1× | 5×+0.5× | 4.5×+1.1× | 3.4×+2.4× | |
| Free cash flow yield | -44.3%-19.2pp | -24.8%+1.3pp | -26.1%-0.3pp | -25.8%+8.1pp | -34%+83.5pp | |
| Earnings yield | -58.5%-29.6pp | -36.7%-6.7pp | -30%-0.2pp | -29.8%+9.5pp | -39.3%+81.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Rapid Micro Biosystems's ratios come from?
- Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
